NCT02079857View on ClinicalTrials.gov

Symptom Management for Irritable Bowel Syndrome

NACompletedINTERVENTIONAL
Enrollment

183

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

November 1, 2019

Study Completion Date

November 1, 2019

Conditions
Irritable Bowel Syndrome
Interventions
OTHER

Standard protocol

Subjects will receive a standard treatment

OTHER

Individualized protocol

Subjects will receive an individualized treatment

OTHER

Sham acupuncture/Placebo moxa

Subjects will receive sham acupuncture/placebo moxa

Trial Locations (1)

10010

NYU Division of Special Studies in Symptom Management, New York

All Listed Sponsors
collaborator

National Institute of Nursing Research (NINR)

NIH

lead

NYU Langone Health

OTHER

NCT02079857 - Symptom Management for Irritable Bowel Syndrome | Biotech Hunter | Biotech Hunter